Independent investigators report Lymphoseek meets all endpoints in NEO3-09 Phase 3 st

[News]

Independent investigators reported today full results from the NEO3-09 study, reaffirming earlier top-line results that showed Lymphoseek met all primary and secondary endpoints and exhibited superior performance to vital blue dye in intraoperative lymphatic mapping (ILM) procedures.

More... (http://www.news-medical.net/news/20110607/Independent-investigators-report-Lymphoseek-meets-all-endpoints-in-NEO3-09-Phase-3-study.aspx)